aod9604 phase 2b trial results weight loss AOD 9604: Peptide Claims vs Clinical Reality, AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH’s side effects. The The effects of a 14

Obese individuals often exhibit both elevated NNMT in adipose tissue and impaired muscle regenerative capacity a connection that NNMTs dual tissue effects could help explain

It has been shown to improve insulin sensitivity, reduce obesity, and prevent diet-induced insulin resistance

These nutrient-rich formulations are promoted for their potential to support energy levels, metabolic efficiency, and fat mobilization

While oral bioavailability is lower than subcutaneous administration, these studies established that even high oral doses maintained excellent safety profiles, though higher doses (54 mg) were associated with increased gastrointestinal discomfort